"Washington Regional is the only not-for-profit, community-owned and locally governed healthcare system in Northwest Arkansas. Its comprehensive healthcare network consists of a 425-bed medical center and over 55 clinic locations."

During the past decade, Washington Regional Medical Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Washington Regional Medical Center" #1 sponsor was "Gynecologic Oncology Group" with 3 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "Abiomed Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Washington Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Abiomed Inc." with 1 trials as a collaborator, "Chiesi Farmaceutici S.p.A." with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Washington Regional Medical Center" are "Cervical Adenocarcinoma" (3 trials), "Heart Failure" (3 trials), "Breast Cancer" (2 trials), "Cervical Adenosquamous Carcinoma" (2 trials) and "Cervical Squamous Cell Carcinoma" (2 trials). Many other conditions were trialed in "Washington Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Washington Regional Medical Center" are "Drug" (7 trials), "Other" (7 trials), "Device" (6 trials), "Biological" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Paclitaxel" (3 trials), "Quality-of-Life Assessment" (3 trials), "Bevacizumab" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Washington Regional Medical Center" are 9 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Washington Regional Medical Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Washington Regional Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Washington Regional Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".